Combined immunotherapy of fusion cells and interleukin-12...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/20 (2006.01) A61K 35/12 (2006.01) A61K 35/14 (2006.01) A61P 35/00 (2006.01) C12N 5/12 (2006.01)

Patent

CA 2555984

The present invention relates to methods and treatment protocols for the immunotherapy of cancer by administering a therapeutically effective dose of fusion cells formed by fusion of autologous dendritic cells and autologous non- dendritic cells in combination with interleukin-12.

La présente invention a trait à des procédés et des protocoles de traitement pour l'immunothérapie du cancer par l'administration d'une dose thérapeutiquement efficace de cellules de fusion formées par la fusion de cellules dendritiques et des cellules non dendritiques autologues en combinaison avec l'interleukine 12.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Combined immunotherapy of fusion cells and interleukin-12... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combined immunotherapy of fusion cells and interleukin-12..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combined immunotherapy of fusion cells and interleukin-12... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1589832

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.